120 related articles for article (PubMed ID: 15371658)
1. Proliferation in non-Hodgkin's lymphomas and its prognostic value related to staging parameters.
Lorand-Metze I; Pereira FG; Costa FP; Metze K
Cell Oncol; 2004; 26(1-2):63-71. PubMed ID: 15371658
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.
Pinto AE; Cabeçadas J; Nóbrega SD; Mendonça E
Diagn Cytopathol; 2003 Oct; 29(4):194-9. PubMed ID: 14506670
[TBL] [Abstract][Full Text] [Related]
3. Effect of treatment on the prognostic value of S-phase fraction in non-Hodgkin's lymphoma.
Joensuu H; Ristamäki R; Söderström KO; Jalkanen S
J Clin Oncol; 1994 Oct; 12(10):2167-75. PubMed ID: 7931487
[TBL] [Abstract][Full Text] [Related]
4. DNA content in high and intermediate grade non-Hodgkin's lymphoma-prognostic significance and clinicopathological correlations.
Cowan RA; Harris M; Jones M; Crowther D
Br J Cancer; 1989 Dec; 60(6):904-10. PubMed ID: 2605100
[TBL] [Abstract][Full Text] [Related]
5. Prognostic relevance of ploidy and proliferative activity evaluation by flow cytometry in poor prognosis non-Hodgkin's lymphomas.
De Lena M; Barletta A; Marzullo F; Lorusso V; Berardi F; Tommasi S; Mangia A; Paradiso A
Haematologica; 1992; 77(1):84-6. PubMed ID: 1398287
[TBL] [Abstract][Full Text] [Related]
6. DNA aneuploidy and cell proliferation in relation to histology and prognosis in patients with Hodgkin's disease.
Erdkamp FL; Breed WP; Schouten HC; Janssen WC; Hoffmann JJ; Wijnen JT; Blijham GH
Ann Oncol; 1993 Jan; 4(1):75-80. PubMed ID: 8435368
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of DNA flow cytometry in non-Hodgkin's lymphoma.
Wu HM
J Tongji Med Univ; 1992; 12(2):65-70. PubMed ID: 1433420
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and predictive evaluation of DNA content, S-phase fraction and immunophenotyping in non-Hodgkin's lymphomas in adults. A prospective study.
Lackowska B; Gruchała A; Niezabitowski A; Radkowski A; Skołyszewski J; Ryś J; Szklarski W; Sokołowski A
Pol J Pathol; 1999; 50(1):23-9. PubMed ID: 10412271
[TBL] [Abstract][Full Text] [Related]
9. DNA content analysis of fine needle aspirates obtained from lymphatic tissue.
Alanen KA; Joensuu H; Klemi PJ
Anal Quant Cytol Histol; 1993 Aug; 15(4):259-64. PubMed ID: 8397647
[TBL] [Abstract][Full Text] [Related]
10. Prognostic implications of proliferating cell nuclear antigen (PCNA), AgNORs and P53 in non-Hodgkin's lymphomas.
Korkolopoulou P; Angelopoulou MK; Kontopidou F; Tsengas A; Patsouris E; Kittas C; Pangalis GA
Leuk Lymphoma; 1998 Aug; 30(5-6):625-36. PubMed ID: 9711925
[TBL] [Abstract][Full Text] [Related]
11. Prognostic utility of silver stained nucleolar organiser region counting in non Hodgkin's lymphoma.
Iyer VK; Raina V; Dawar R
Indian J Cancer; 2000 Dec; 37(4):140-7. PubMed ID: 12018565
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA
J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009
[TBL] [Abstract][Full Text] [Related]
13. DNA ploidy and cell kinetic characteristics in canine non-Hodgkin's lymphoma.
Teske E; Rutteman GR; Kuipers-Dijkshoorn NJ; van Dierendonck JH; van Heerde P; Cornelisse CJ
Exp Hematol; 1993 Apr; 21(4):579-84. PubMed ID: 8462667
[TBL] [Abstract][Full Text] [Related]
14. Morphometric analysis of AgNORs in the lymph node lesions.
Arora B; Jain R; Kumar S; Rekhi B; Arora H; Arora DR
Adv Clin Path; 2002 Apr; 6(2):95-9. PubMed ID: 19753731
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of lymphocyte homing receptor and S phase fraction in non-Hodgkin's lymphoma.
Jalkanen S; Joensuu H; Klemi P
Blood; 1990 Apr; 75(7):1549-56. PubMed ID: 2180497
[TBL] [Abstract][Full Text] [Related]
16. Biologic progression in non-Hodgkin's lymphoma. A flow cytometric study.
Joensuu H; Klemi PJ; Jalkanen S
Cancer; 1990 Jun; 65(11):2564-71. PubMed ID: 2337874
[TBL] [Abstract][Full Text] [Related]
17. AgNORs predictive value of prognosis in non-Hodgkin's lymphoma: comparison with flow cytometric cell cycle analysis.
Jakić-Razumović J; Uzarević B; Petrovecki M; Marusić M; Radman I; Labar B
Leuk Lymphoma; 1992 May; 7(1-2):165-70. PubMed ID: 1472929
[TBL] [Abstract][Full Text] [Related]
18. Gastric lymphomas in Turkey. Analysis of prognostic factors with special emphasis on flow cytometric DNA content.
Aydin ZD; Barista I; Canpinar H; Sungur A; Tekuzman G
Cancer; 2000 Jul; 89(1):12-20. PubMed ID: 10896995
[TBL] [Abstract][Full Text] [Related]
19. Validation of the international prognostic index in working formulation group A low-grade non-Hodgkin's lymphoma: retrospective analysis of 137 patients from the Gruppo Italiano per lo Studio dei Linfomi registry.
Stelitano C; Baldini L; Pieresca C; Callea V; Angrilli F; Clò V; Partesotti G; Merli F; Cavanna L; Morabito F; Federico M; Brugiatelli M; Silingardi V
Haematologica; 2000 Feb; 85(2):154-9. PubMed ID: 10681722
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of the immunophenotype versus the International Prognostic Index in aggressive non-Hodgkin's lymphoma.
Intragumtornchai T; Rotnakkarin P; Sutcharitchan P; Wannagrairoj P
Clin Lymphoma; 2003 Jun; 4(1):52-5. PubMed ID: 12837156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
